These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2312980)

  • 21. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
    Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
    Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and prognostic significance of late ventricular potentials in patients with hypertrophic cardiomyopathy].
    Legkogonov AV
    Ter Arkh; 1998; 70(4):20-4. PubMed ID: 9612896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms of hypertrophic cardiomyopathy, with special emphasis on syncope and postprandial exacerbation of symptoms.
    Gilligan DM; Nihoyannopoulos P; Fletcher A; Sbarouni E; Dritsas A; Oakley CM
    Clin Cardiol; 1996 May; 19(5):371-8. PubMed ID: 8723595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
    Chang SM; Nagueh SF; Spencer WH; Lakkis NM
    J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syncope in hypertrophic cardiomyopathy.
    McKenna W; Harris L; Deanfield J
    Br Heart J; 1982 Feb; 47(2):177-9. PubMed ID: 7199348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal-averaged electrocardiography in hypertrophic cardiomyopathy.
    Cripps TR; Counihan PJ; Frenneaux MP; Ward DE; Camm AJ; McKenna WJ
    J Am Coll Cardiol; 1990 Apr; 15(5):956-61. PubMed ID: 2312981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic cardiomyopathy in Greece: clinical course and outcome.
    Kyriakidis M; Triposkiadis F; Anastasakis A; Theopistou A; Tocta R; Barbetseas J; Gialafos J
    Chest; 1998 Oct; 114(4):1091-6. PubMed ID: 9792582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy.
    Finocchiaro G; Pinamonti B; Merlo M; Brun F; Barbati G; Sinagra G
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):810-8. PubMed ID: 22885530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertrophic cardiomyopathy: non-invasive assessment of diastolic and systolic functional parameters in relation to heart rate.
    Nienaber CA; Spielmann RP; Geiger M; Clausen A; Kuck KH; Montz R
    Nuklearmedizin; 1985 Dec; 24(5-6):196-200. PubMed ID: 4094898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
    Maron BJ; Savage DD; Wolfson JK; Epstein SE
    Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of giant negative T waves in hypertrophic cardiomyopathy.
    Alfonso F; Nihoyannopoulos P; Stewart J; Dickie S; Lemery R; McKenna WJ
    J Am Coll Cardiol; 1990 Apr; 15(5):965-71. PubMed ID: 2312983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed electrical stimulation in patients with hypertrophic cardiomyopathy.
    Kuck KH; Kunze KP; Geiger M; Costard A; Schlüter M
    Z Kardiol; 1987; 76 Suppl 3():131-6. PubMed ID: 3433865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Watson RM; Schwartz JL; Maron BJ; Tucker E; Rosing DR; Josephson ME
    J Am Coll Cardiol; 1987 Oct; 10(4):761-74. PubMed ID: 3655144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Biagini E; Pazzi C; Olivotto I; Musumeci B; Limongelli G; Boriani G; Pacileo G; Mastromarino V; Bacchi Reggiani ML; Lorenzini M; Lai F; Berardini A; Mingardi F; Rosmini S; Resciniti E; Borghi C; Autore C; Cecchi F; Rapezzi C
    Am J Cardiol; 2016 Aug; 118(3):432-9. PubMed ID: 27289293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hemodynamic deterioration during rapid atrial pacing in patients with hypertrophic cardiomyopathy.
    Nakatani M; Yokota Y; Yokoyama M
    Clin Cardiol; 1996 May; 19(5):385-92. PubMed ID: 8723597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
    Cannon RO; Dilsizian V; O'Gara PT; Udelson JE; Schenke WH; Quyyumi A; Fananapazir L; Bonow RO
    Circulation; 1991 May; 83(5):1660-7. PubMed ID: 2022023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.